MUFG Securities EMEA’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Sell
4,308
-202
-4% -$39.6K 0.01% 434
2026
Q1
$884K Sell
4,510
-50
-1% -$9.71K 0.01% 413
2025
Q4
$791K Buy
4,560
+2,420
+113% +$441K 0.01% 448
2025
Q3
$408K Buy
2,140
+1,813
+554% +$322K 0.01% 409
2025
Q2
$58.7K Buy
+327
New +$56.8K ﹤0.01% 419
2023
Q1
Sell
-43,132
Closed -$6.75M 129
2022
Q4
$6.75M Buy
+43,132
New +$6.2M 0.11% 56
2021
Q4
Sell
-37,800
Closed -$5.49M 212
2021
Q3
$5.49M Buy
+37,800
New +$5.53M 0.06% 140
2021
Q2
Sell
-85,000
Closed -$10.9M 327
2021
Q1
$10.9M Sell
85,000
-134,000
-61% -$16.5M 0.09% 155
2020
Q4
$26.1M Buy
219,000
+76,000
+53% +$9.26M 0.2% 89
2020
Q3
$16.4M Buy
143,000
+120,256
+529% +$14.2M 0.16% 106
2020
Q2
$2.59M Sell
22,744
-187,256
-89% -$19.9M 0.02% 268
2020
Q1
$16.9M Buy
+210,000
New +$21.7M 0.17% 101
2019
Q4
Sell
-14,698
Closed -$1.57M 500
2019
Q3
$1.57M Buy
+14,698
New +$1.51M 0.02% 254
2019
Q2
Sell
-3,830
Closed -$344K 416
2019
Q1
$344K Sell
3,830
-86,820
-96% -$7.52M ﹤0.01% 453
2018
Q4
$7.55M Buy
90,650
+80,345
+780% +$7.53M 0.08% 139
2018
Q3
$1.11M Sell
10,305
-44,847
-81% -$4.92M 0.02% 313
2018
Q2
$6.06M Buy
+55,152
New +$5.75M 0.11% 131

Other funds holding DGX

MUFG Securities EMEA's DGX Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Quest Diagnostics (DGX) stake by 4.5% in Q2 2026, selling an estimated $39.6K and leaving 4,308 shares worth $913K. The position accounts for 0.01% of the portfolio, ranked #434.

MUFG Securities EMEA first reported a position in DGX in Q2 2018 and has held it in 17 quarters since. The position peaked at $26.1M in Q4 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • MUFG Securities EMEA held 4,308 shares of Quest Diagnostics worth $913K as of Q2 2026.
  • MUFG Securities EMEA sold 202 Quest Diagnostics shares in Q2 2026, an estimated $39.6K.
  • Quest Diagnostics made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #434 holding.
  • MUFG Securities EMEA first reported a position in Quest Diagnostics in Q2 2018 and has held it in 17 quarters since.
  • MUFG Securities EMEA's Quest Diagnostics position peaked at $26.1M in Q4 2020.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.